Physician profile
Daniel Lim
NPI 1790121507
$27,853.28
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $164 · 2021: $1,286 · 2022: $1,600.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $16,503.14 | 2019-2022 | |
| Smith+Nephew, INC. | $2,992.26 | 2019 | |
| Stryker Corporation | $2,244.89 | 2019-2021 | |
| Micromed INC | $2,162.00 | 2019 | |
| Djo, LLC | $1,875.00 | 2019 | |
| Impactortho, INC. | $1,557.11 | 2021-2022 | |
| Advanced Orthopaedic Solutions, INC. | $163.56 | 2020 | |
| Acumed LLC | $127.09 | 2019 | |
| Depuy Synthes Sales INC. | $75.13 | 2019 | |
| Zimmer Biomet Holdings, INC. | $65.52 | 2022 | |
| Bioventus LLC | $41.61 | 2021-2022 | |
| Pacira Therapeutics, INC. | $23.43 | 2019 | |
| Elevate Surgical Co | $22.54 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.